Clinical Trial Update: PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy

View source ↗

Summary

This trial evaluates whole-body dynamic PET/CT imaging with FDG to assess metastatic melanoma in patients undergoing immunotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University Hospital, Brest | Conditions: Metastatic Melanoma | Status: RECRUITING